Episode Details

Back to Episodes

Alibaba’s New Model Might Give US Rivals A Run For Their Money, And AstraZeneca And Bristol Myers Squibb Could Join Forces

Published 2 months ago
Description

Chinese tech titan Alibaba is making its latest and greatest model available open-weight, and making a bid for AI dominance – while AstraZeneca and Bristol Myers Squibb are reportedly considering joining forces, but it’s proving a bitter pill for investors to swallow.

Today’s stories:

Try Finimize Pro 

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us